 SEATTLE, Aug. 10, 2021 GLOBE NEWSWIRE -- Nautilus Biotechnology, Inc. NASDAQ: NAUT; or Nautilus, a life sciences company creating a platform technology for quantifying and unlocking the complexity of the proteome, today reported financial results for the second quarter ended June 30, 2021. 